NCT02479867View on ClinicalTrials.gov

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions

Healthy

Interventions

DRUG

Cefadroxil

1 tablet from test vs 1 tablet from reference

Trial Locations (1)

Unknown

Genuine Research Center GRC, Cairo

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Genuine Research Center, Egypt

INDUSTRY

NCT02479867 - A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma) | Biotech Hunter | Biotech Hunter